Medicines: Apply for a Parallel Import License

13 October 2022 — MHRA published the guidance on how to get a parallel import license.

The UK parallel import licensing scheme lets a medicine authorized in an EEA Member State be marketed in the UK, as long as the imported product has no therapeutic difference from the cross-referenced UK product. MR-DC product list updated on 7 October 2022.

Read more online 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /